Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Equity Ratio (2020 - 2025)

SOPHiA GENETICS's Equity Ratio history spans 6 years, with the latest figure at 0.48 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 20.42% to 0.48 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.48, a 20.42% decrease, with the full-year FY2025 number at 0.48, down 20.42% from a year prior.
  • Equity Ratio hit 0.48 in Q4 2025 for SOPHiA GENETICS, down from 0.37 in the prior quarter.
  • Over the last five years, Equity Ratio for SOPH hit a ceiling of 0.22 in Q2 2025 and a floor of 0.48 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.16 across 5 years, with a median of 0.23 in 2021.
  • The widest YoY moves for Equity Ratio: up 160.62% in 2022, down 87.77% in 2022.
  • Tracing SOPH's Equity Ratio over 5 years: stood at 0.23 in 2021, then plummeted by 55.85% to 0.36 in 2022, then dropped by 6.83% to 0.38 in 2023, then decreased by 5.03% to 0.4 in 2024, then dropped by 20.42% to 0.48 in 2025.
  • Business Quant data shows Equity Ratio for SOPH at 0.48 in Q4 2025, 0.37 in Q3 2025, and 0.22 in Q2 2025.